カテゴリー： QYResearch, 世界

グラム陰性菌感染症治療薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18513）・商品コード：DATA909X18513
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、グラム陰性菌感染症治療薬の世界市場について調査・分析し、グラム陰性菌感染症治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経腸治療、非経口治療、局所治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界のグラム陰性菌感染症治療薬市場動向
・主要企業別マーケットシェア
・グラム陰性菌感染症治療薬の種類別市場規模2014-2019
（経腸治療、非経口治療、局所治療）
・グラム陰性菌感染症治療薬の用途別市場規模2014-2019
（病院、診療所、その他）
・グラム陰性菌感染症治療薬の北米市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬の中国市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬のインド市場：主要企業・種類別/用途別市場規模
・グラム陰性菌感染症治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Baxter、Sanofi、GlaxoSmithKline、Novartis、Pfizer、Takeda、Nektar Therapeutics、Sumitomo、Targeted Genetics）
・グラム陰性菌感染症治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.In 2018, the global Gram-Negative Bacterial Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gram-Negative Bacterial Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gram-Negative Bacterial Infection Therapeutics development in North America, Europe and Asia-Pacific.

The key players covered in this study
Baxter
Sanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics

Market segment by Type, the product can be split into
Enteral Treatment
Parenteral Treatment
Topical Treatment

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Gram-Negative Bacterial Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Gram-Negative Bacterial Infection Therapeutics development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gram-Negative Bacterial Infection Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Enteral Treatment
1.4.3 Parenteral Treatment
1.4.4 Topical Treatment
1.5 Market by Application
1.5.1 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gram-Negative Bacterial Infection Therapeutics Market Size
2.2 Gram-Negative Bacterial Infection Therapeutics Growth Trends by Regions
2.2.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2019-2025)
2.2.2 Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Gram-Negative Bacterial Infection Therapeutics Market Size by by Players
3.1.1 Global Gram-Negative Bacterial Infection Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Area Served
3.3 Key Players Gram-Negative Bacterial Infection Therapeutics Product/Solution/Service
3.4 Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2014-2019)
4.2 Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size (2014-2019)
5.2 Gram-Negative Bacterial Infection Therapeutics Key Players in North America
5.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
5.4 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application

6 Europe
6.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size (2014-2019)
6.2 Gram-Negative Bacterial Infection Therapeutics Key Players in Europe
6.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type
6.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (2014-2019)
7.2 Gram-Negative Bacterial Infection Therapeutics Key Players in Asia-Pacific
7.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type
7.4 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application

8 International Players Profiles
8.1 Baxter
8.1.1 Baxter Company Details
8.1.2 Company Description and Business Overview
8.1.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.1.4 Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019))
8.1.5 Baxter Recent Development
8.2 Sanofi
8.2.1 Sanofi Company Details
8.2.2 Company Description and Business Overview
8.2.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.2.4 Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.2.5 Sanofi Recent Development
8.3 GlaxoSmithKline
8.3.1 GlaxoSmithKline Company Details
8.3.2 Company Description and Business Overview
8.3.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.3.4 GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.3.5 GlaxoSmithKline Recent Development
8.4 Novartis
8.4.1 Novartis Company Details
8.4.2 Company Description and Business Overview
8.4.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.4.4 Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.4.5 Novartis Recent Development
8.5 Pfizer
8.5.1 Pfizer Company Details
8.5.2 Company Description and Business Overview
8.5.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.5.4 Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.5.5 Pfizer Recent Development
8.6 Takeda
8.6.1 Takeda Company Details
8.6.2 Company Description and Business Overview
8.6.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.6.4 Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.6.5 Takeda Recent Development
8.7 Nektar Therapeutics
8.7.1 Nektar Therapeutics Company Details
8.7.2 Company Description and Business Overview
8.7.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.7.4 Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.7.5 Nektar Therapeutics Recent Development
8.8 Sumitomo
8.8.1 Sumitomo Company Details
8.8.2 Company Description and Business Overview
8.8.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.8.4 Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.8.5 Sumitomo Recent Development
8.9 Targeted Genetics
8.9.1 Targeted Genetics Company Details
8.9.2 Company Description and Business Overview
8.9.3 Gram-Negative Bacterial Infection Therapeutics Introduction
8.9.4 Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
8.9.5 Targeted Genetics Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Gram-Negative Bacterial Infection Therapeutics Key Market Segments
Table Key Players Gram-Negative Bacterial Infection Therapeutics Covered
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Enteral Treatment Figures
Table Key Players of Enteral Treatment
Figuer Parenteral Treatment Figures
Table Key Players of Parenteral Treatment
Figuer Topical Treatment Figures
Table Key Players of Topical Treatment
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Gram-Negative Bacterial Infection Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Share by by Players (2014-2019)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Share by by Players in 2018
Table Global Gram-Negative Bacterial Infection Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gram-Negative Bacterial Infection Therapeutics Product/Solution/Service
Table Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Type (2014-2019)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application (2014-2019)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application in 2018
Figure North America Gram-Negative Bacterial Infection Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Gram-Negative Bacterial Infection Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Gram-Negative Bacterial Infection Therapeutics Market Share (2018-2019)
Table North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Gram-Negative Bacterial Infection Therapeutics Market Share by Type 2014-2019
Table North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Gram-Negative Bacterial Infection Therapeutics Market Share by Application 2014-2019
Figure Europe Gram-Negative Bacterial Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Gram-Negative Bacterial Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Gram-Negative Bacterial Infection Therapeutics Market Share (2018-2019)
Table Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Type 2014-2019
Table Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Application 2014-2019
Figure Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Gram-Negative Bacterial Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Gram-Negative Bacterial Infection Therapeutics Market Share (2018-2019)
Table Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Type 2014-2019
Table Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Application 2014-2019
Table Baxter Company Details
Table Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Baxter Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Baxter Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Sanofi Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Takeda Company Details
Table Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Takeda Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Takeda Recent Development
Table Nektar Therapeutics Company Details
Table Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Nektar Therapeutics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Nektar Therapeutics Recent Development
Table Sumitomo Company Details
Table Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Sumitomo Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Sumitomo Recent Development
Table Targeted Genetics Company Details
Table Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business 2014-2019 (Million US$)
Figure Targeted Genetics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2014-2019)
Table Targeted Genetics Recent Development
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Regions in 2025
Figure North America Gram-Negative Bacterial Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gram-Negative Bacterial Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size by Product (2019-2025)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size by Product in 2025
Table Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2019-2025)
Figure Global Gram-Negative Bacterial Infection Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Baxter、Sanofi、GlaxoSmithKline、Novartis、Pfizer、Takeda、Nektar Therapeutics、Sumitomo、Targeted Genetics

★調査レポート[グラム陰性菌感染症治療薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18513)販売に関する免責事項を必ずご確認ください。
★調査レポート[グラム陰性菌感染症治療薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆